event
IDM CPD-Accredited Special Seminar: Lesion-centric pharmacokinetic (PK) & pharmacodynamic (PD) considerations for TB drug discovery and regimen design
17 March 2025
Speaker: Assistant Prof Jansy Sarathy
Hackensack Meridian School of Medicine Center for Discovery and Innovation
Host: Dr Dirk Lamprecht
H3D
IDM CPD-Accredited Special Seminar Program 2025
17 March 2025 | 11:00 - 12:00
Wolfson Pavilion Lecture Theatre, IDM Building
Jansy Sarathy is an Assistant Professor at the Hackensack Meridian School of Medicine in Nutley, New Jersey, and an Assistant Member at the Center for Discovery and Innovation. Her research focuses on applying site-of-disease pharmacokinetic-pharmacodynamic (PK-PD) concepts to rationalize TB treatment efficacy. She is particularly interested in addressing nonreplicating persistent populations of M. tuberculosis in hard-to-treat sites of infection.
Sarathy graduated from National University of Singapore, School of Medicine after the completion of a graduate research program at the Novartis Institute for Tropical Diseases. She was a postdoctoral research fellow at the Public Health Research Institute, Rutgers, where she trained under veteran TB pharmacologist Veronique Dartois. She then pursued a faculty position at the Center for Discovery and Innovation.